Other languages bioAffinity Technologies, Inc.

Equities

BIAF

US09076W1099

Market Closed - Nasdaq Other stock markets 01:30:00 30/04/2024 am IST			5-day change	1st Jan Change
2.53 ^USD	+6.75%		-15.67%	+72.05%

01/04	BioAffinity Technologies, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
20/03	BioAffinity Technologies, Inc. announced that it has received $2.624 million in funding	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

BioAffinity Technologies, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	02/04
BioAffinity Technologies Closes $2.5 Million Equity Offerings	09/03
BioAffinity Technologies, Inc. Appoints Sandeep Bansal to Medical and Scientific Advisory Board	06/02
BioAffinity Technologies, Inc. Appoints Jamie Platt, Ph.D., to its Board of Directors	05/12
BioAffinity Technologies, Inc. Provides Earnings Guidance for the Year 2023 and for the Next 12 Months(fourth quarter 2023 to third quarter 2024)	15/11
BioAffinity Technologies, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	15/11
BioAffinity Technologies, Inc. Appoints Dallas J. Coleman as National Director of Sales	06/11
BioAffinity Technologies Files Registration Statement for Planned Offering of Units at Assumed Price of $1.62 a Unit	21/23/21
BioAffinity Technologies, Inc. Announces Board Changes	21/23/21
BioAffinity Technologies Unit Acquires Precision Pathology Services Laboratory Assets; Shares Rise	19/23/19
BioAffinity Technologies, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	15/23/15
AMA Issues CPT Code for bioAffinity Technologiesâ€™ CyPathÂ® Lung Test for Early-Stage Lung Cancer	12/23/12
BioAffinity Technologies, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	15/23/15
BioAffinity Technologies, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	01/23/01
BioAffinity Technologies Announces Publication of Peer-Reviewed Paper on Proprietary Beads Used in CyPath Lung for Noninvasive Detection of Early-Stage Lung Cancer	28/23/28
BioAffinity Technologies, Inc. Appoints Julie Anne Overton as Director of Corporate Communications	13/23/13
Sector Update: Health Care Stocks Still Sagging Near Close	25/23/25
Sector Update: Healthcare	25/23/25
Top Midday Gainers	25/23/25
BioAffinity Technologies, Inc. Announces Publication of Results of Clinical Trial in Peer-Reviewed Journal Respiratory Research	24/23/24

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages bioAffinity Technologies, Inc.

Equities

BIAF

US09076W1099

Other languages

Filters